Role of deferiprone in chelation therapy for transfusional iron overload

被引:167
作者
Hoffbrand, AV
Cohen, A
Hershko, C
机构
[1] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
[2] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
[3] Shaare Zedek Med Ctr, Dept Med, IL-91000 Jerusalem, Israel
关键词
D O I
10.1182/blood-2002-06-1867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:17 / 24
页数:8
相关论文
共 92 条
[1]   Meta-analytic review of the clinical effectiveness of oral deferiprone (L1) [J].
Addis, A ;
Loebstein, R ;
Koren, G ;
Einarson, TR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (01) :1-6
[2]   LONG-TERM ASSESSMENT OF EFFICACY AND SAFETY OF L1, AN ORAL IRON CHELATOR, IN TRANSFUSION DEPENDENT THALASSEMIA - INDIAN TRIAL [J].
AGARWAL, MB ;
GUPTE, SS ;
VISWANATHAN, C ;
VASANDANI, D ;
RAMANATHAN, J ;
DESAI, N ;
PUNIYANI, RR ;
CHHABLANI, AT .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :460-466
[3]  
ALREFAIE FN, 1992, BLOOD, V80, P593
[4]  
ALREFAIE FN, 1994, EUR J HAEMATOL, V53, P298
[5]   RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS [J].
ALREFAIE, FN ;
HERSHKO, C ;
HOFFBRAND, AV ;
KOSARYAN, M ;
OLIVIERI, NF ;
TONDURY, P ;
WONKE, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (01) :224-229
[6]   ZINC CONCENTRATION IN PATIENTS WITH IRON OVERLOAD RECEIVING ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE OR DESFERRIOXAMINE [J].
ALREFAIE, FN ;
WONKE, B ;
WICKENS, DG ;
AYDINOK, Y ;
FIELDING, A ;
HOFFBRAND, AV .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) :657-660
[7]   PHARMACOKINETICS OF THE ORAL IRON CHELATOR DEFERIPRONE (L(1)) IN PATIENTS WITH IRON OVERLOAD [J].
ALREFAIE, FN ;
SHEPPARD, LN ;
NORTEY, P ;
WONKE, B ;
HOFFBRAND, AV .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) :403-408
[8]  
ALREFAIE FN, 1993, RECENT ADV HAEMATOLO, V7, P185
[9]  
Alymara V., 2002, HEMATOL J, V3, P81
[10]   Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia [J].
Anderson, LJ ;
Wonke, B ;
Prescott, E ;
Holden, S ;
Walker, JM ;
Pennell, DJ .
LANCET, 2002, 360 (9332) :516-520